Randomized phase II trial of weekly vs. q 2-weekly vs. q 3-weekly nanoparticle albumin-bound paclitaxel with bevacizumab as first-line therapy for metastatic breast cancer Meeting Abstract

  

Authors:	Seidman, A. D.; Conlin, A. K.; Bach, A.; Forero-Torres, A.; Wright, G.; Hackney, M. H.; Clawson, A.; Schofield, D.; Iglesias, J.; Hudis, C. A.
Abstract Title:	Randomized phase II trial of weekly vs. q 2-weekly vs. q 3-weekly nanoparticle albumin-bound paclitaxel with bevacizumab as first-line therapy for metastatic breast cancer
Meeting Title:	34th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title:	Cancer Research
Volume:	71
Issue:	24 Suppl.
Meeting Dates:	2011 Dec 6-10
Meeting Location:	San Antonio, TX
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2011-12-01
Language:	English
ACCESSION:	WOS:000209699800261
DOI:	10.1158/0008-5472.sabcs11-p1-14-01
PROVIDER:	wos
Notes:	Meeting Abstract: P1-14-01 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/99109